Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion and Varenicline for Smoking Cessation in Ontario
NCT01023659Phase 4Completed
- Sponsor
- Center for Addiction and Mental Health
- Start
- Apr 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of varenicline, bupropion in Tobacco Use Disorder (TUD), sponsored by Center for Addiction and Mental Health. Started Apr 2010; status: completed.
02
Drugs
vareniclinebupropion
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT01023659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01023659.